Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 August 2021GlobeNewsWire • 08/11/21
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 9 August 2021GlobeNewsWire • 08/10/21
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 5 August 2021GlobeNewsWire • 08/09/21
Novo Nordisk A/S (NVO) CEO Lars Jorgensen on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
BofA Upgrades Novo Nordisk, Says Wegovy Obesity Drug Launch 'Far Exceeded' ExpectationsBenzinga • 08/05/21
Novo Nordisk Shares Are Trading Higher As GLP-1 Treatments Boost Q2 Topline, Bottom-lineBenzinga • 08/04/21
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena's ATTR Amyloidosis ProgrammeGlobeNewsWire • 07/12/21
Now on Sale at Walmart: Insulin That's Cheaper Than Brands from Lilly, Sanofi, or Novo NordiskBarrons • 06/29/21
Novo Nordisk's Higher Dose Of Semaglutide Trumped 1-mg Predecessor On Blood Sugar, Weight ReductionBenzinga • 06/28/21
Investigational 2.0 mg dose of Ozempic® (semaglutide) demonstrates superior reductions in blood sugar vs Ozempic® 1.0 mg in adults with type 2 diabetes in a phase 3 trialGlobeNewsWire • 06/26/21
This Leading Healthcare Company's New Obesity Treatment Has Great PotentialThe Motley Fool • 06/23/21
Novo Nordisk, Lumen Bioscience Collaborate For Oral Biologics For Cardiometabolic DiseasesBenzinga • 06/16/21